Smith & Nephew Share Price | |
---|---|
Price | 981.00 |
Bid | 983.00 |
Ask | 983.20 |
Change | 16.60 (1.72%) |
Volume | 4,932,607 |
Open | 965.00 |
High | 986.20 |
Low | 965.00 |
Prev. Close | 964.40 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 874.33m |
Market Capitalisation | £8.58b |
Market Size | 2,000 |
52 Week High | 1,316.00 |
52 Week High Date | 02-May-2023 |
52 Week Low | 887.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 8,868 |
---|---|
Vol. Sold | 2,378,741 |
Sold Value | £23.32m |
Vol. Bought | 829,673 |
Bought Value | £8.13m |
PE Ratio | 41.35774 |
Earnings | 23.71987 |
Dividend | 30.27 |
Yield | 3.086% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 18:52:03 | 976.799 | 2,347 | Unknown* | 983.00 | 983.20 | 22.93k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:51:52 | 981.166 | 2,224 | Unknown* | 983.00 | 983.20 | 21.82k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:08:43 | 978.60 | 145 | Unknown* | 983.00 | 983.20 | 1,419 | O Ordinary Was reported as OTC |
26-Apr-24 | 18:08:43 | 980.297 | 35,952 | Unknown* | 983.00 | 983.20 | 352.44k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:08:29 | 976.988 | 150,000 | Unknown* | 983.00 | 983.20 | 1m | O Ordinary Was reported as OTC |
26-Apr-24 | 18:08:25 | 980.623 | 83,363 | Unknown* | 983.00 | 983.20 | 817.48k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:06:50 | 979.825 | 158,223 | Unknown* | 983.00 | 983.20 | 2m | O Ordinary Was reported as OTC |
26-Apr-24 | 18:04:31 | 981.00 | 5,309 | Unknown* | 983.00 | 983.20 | 52.08k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:02:54 | 980.416 | 19,573 | Unknown* | 983.00 | 983.20 | 191.90k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:02:53 | 981.00 | 119,570 | Unknown* | 983.00 | 983.20 | 1m | O Ordinary Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
17-Jan-24 | 09-Jan-24 | Buy | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 23.19 | USD | 408 | 107,222 |
14-Nov-23 | 13-Nov-23 | Sell | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 1,001.09 | GBX | 1,961 | 106,814 |
14-Nov-23 | 13-Nov-23 | Transfer From | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 0.00 | 4,788 | 106,814 | |
10-Nov-23 | 10-Nov-23 | Buy | Jeremy (Jez) Maiden held the position of Independent Non-Executive Director at the time of this trade.Jeremy (Jez) Maiden | 1,007.75 | GBX | 1,000 | 1,000 |
10-Nov-23 | 08-Nov-23 | Sell | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 987.80 | GBX | 1,771 | 103,987 |
Smith+Nephew is a portfolio medical device company focused on the repair, regeneration and replacement of soft and hard tissue.